Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Provera (Cancer)
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Provera 100mg tablets
0803020H0BDAAAC
|
Provera (Cancer) | Medroxyprogesterone acetate | Malignant Disease and Immunosuppression | 586 |
|
Provera 200mg tablets
0803020H0BDACAD
|
Provera (Cancer) | Medroxyprogesterone acetate | Malignant Disease and Immunosuppression | 500 |
|
Provera 400mg tablets
0803020H0BDADAF
|
Provera (Cancer) | Medroxyprogesterone acetate | Malignant Disease and Immunosuppression | 169 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.